For the first timehttps://innovationtoronto.com/wp-content/uploads/2019/10/213780_webwe4.jpg, scientists have identified a simple way that can effectively transport medication into the brain – which could lead to improved treatments for neurological and neurodegenerative diseases.
In a study published today in Nature Communications, scientists from Newcastle University, UK, have led an international team in a major breakthrough in unlocking the secrets of how medications can infiltrate the brain.
Blood capillaries in the brain are not permeable to many drugs and the majority are excluded from the brain by a protective barrier, called the blood-brain-barrier (BBB), and current treatment options are risky.
Some viruses, however, have found ways to bypass the BBB and enter the brain. To treat certain neurological and neurodegenerative diseases, medication has to use modified viruses to bypass this barrier and deliver drugs to the area.
The team has now engineered small particles, similar to the size of viruses, from a peptide that can behave like a carrier to the brain and can be packed with drugs for intravenous injection.
Professor Moein Moghimi, who led the research, said: “Crossing the blood-brain-barrier has hindered the industry from effectively addressing central nervous system diseases, including brain tumours, and many neurological diseases like Parkinson’s, Alzheimer’s and Huntington’s.
“This breakthrough – based on more than 10 years of research – has significant implications for crossing BBB and other biological barriers that have created challenges for drug delivery.
“Our breakthrough allows for minimally invasive combination delivery through an intravenous injection of various drugs, peptides and nucleic acid therapeutics to the brain.”
At present, treatment of neurological disorders involves difficulties in ‘packaging’ viruses safely and medication is usually administered by injection into the cerebrospinal fluid, which is not without risks.
The new technological breakthrough in delivering genetic materials to cells in the brain has used a peptide component from a virus that targets the brain (a bacteriophage fd). The peptide was synthesised and modified slightly, and when water was added it spontaneously formed a ‘small, hairy particle’.
Scientists found that when the developed particle was injected into a mouse model, the system targeted the brain, crossing the blood-brain-barrier, reaching neurons and microglia cells in the brain.
Professor Moghimi added: “We are very excited by our research – our delivery system is versatile and amenable to modifications, so, in principle, we can hopefully address shortfalls in drug delivery to the brain through intravenous injection.
“We have a long way to go, but we hope that our technology platform may open up many opportunities to address neurodegenerative diseases with modern therapeutics and genetic drugs.”
Through the mouse model, scientists found their technique was safe. Further research will test the technology in animal disease models in preparation for clinical trials.
Gary Leo, SMDG’s SVP of Corporate Development and former national president and CEO of the ALS Association, USA, said: “Bearing in mind the fact that neurological disorders are growing in incidence faster than any other disease class worldwide, governments will face a huge burden and increasing demands for treatment and support services.
“New knowledge is required to develop effective treatment strategies, and the new technology reported in Nature Communications is a promising achievement to fulfil these goals.”
The Latest on: Blood-brain-barrier
via Google News
The Latest on: Blood-brain-barrier
- Voyager Therapeutics Prioritizes Pipeline and Reports Second Quarter 2022 Financial and Operating Resultson August 4, 2022 at 2:34 pm
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, today unveiled its ...
- Odyssey Health, Inc. (ODYY) Drug Product Testing Aims To Give Military Veterans New Weapon For Fighting Brain Injuryon August 4, 2022 at 11:54 am
The medical care needs of military personnel are once again in the spotlight following a political dust-up over service members' exposure ...
- Covid and the brain | That fog in the grey cellson August 4, 2022 at 4:25 am
From impaired cognitive functions and mood disorders to neurological damage, the coronavirus's impact on brain health cannot be taken lightly ...
- Glyphosate Weed Killer Crosses Blood-Brain Barrier, Linked to Alzheimer’s and Other Neurodegenerative Diseaseson August 3, 2022 at 9:01 pm
An Arizona State University (ASU) study shows that the popular herbicide glyphosate can infiltrate the brain through the blood (blood-brain barrier), increasing neurological disease risk. The ...
- Voyager Therapeutics Presents New Data Demonstrating Novel Candidate Therapeutic Antibodies Reduced Tau Pathology in Multiple Preclinical Modelson August 3, 2022 at 8:32 am
Novel passive antibodies bind to paired helical filamentous tau and inhibit propagation of pathological tau. Vectorized antibody demonstrates durable CNS expression more than six ...
- Do you know iron buildup in brain linked to higher risk for movement disorders? Study revealson August 2, 2022 at 7:56 am
The body absorbs too much iron due to a condition known as hereditary hemochromatosis, which is brought on by a gene mutation. This causes tissue damage and diseases like liver disease, heart disease, ...
- Combining ultrasound and bubbles helps medicines reach the brainon August 2, 2022 at 6:16 am
Luckily, the brain has a filter that protects it and the rest of the central nervous system from foreign elements like pathogens that can damage the tissue.
- Iron buildup in brain linked to higher risk for movement disorderson August 1, 2022 at 1:11 pm
A disorder called hereditary hemochromatosis, caused by a gene mutation, results in the body absorbing too much iron, leading to tissue damage and conditions like liver disease, heart problems and ...
- Common Herbicide Found To Cross the Blood–Brain Barrieron August 1, 2022 at 12:55 am
The research demonstrates, for the first time, that glyphosate successfully crosses the blood-brain barrier and infiltrates the brain. Once there, it acts to enhance levels of a critical factor known ...
- New study shows that a commonly used agricultural herbicide crosses the blood-brain barrieron July 26, 2022 at 5:00 pm
Various environmental contaminants have also been implicated as possible players in the development or advancement of neurodegenerative disease. Among these is a broad-spectrum herbicide, known as ...
via Bing News